Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04168645 · ClinicalTrials.gov registry record · NA

Inpatient Cognitive-Behavioral Therapy to Reduce Suicide Risk Post-Discharge

A NA study, sponsored by Hartford Hospital.

Completed
Registry status
NA
Development phase
213
Enrollment target

NCT04168645 is a NA study that has completed, run by Hartford Hospital. The registered enrollment target is 213 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04168645, a NA study, has completed, sponsored by Hartford Hospital.

COMPLETED
Registry status
NA
Development phase
213 participants
Enrollment target

Study Summary

The goal of this randomized-controlled trial is to determine whether adding brief cognitive-behavioral therapy for suicide prevention (BCBT) to inpatient treatment improves suicide-related outcomes after the person leaves the hospital. The study will also determine whether being diagnosed with a substance use disorder impacts these outcomes. Participants will either receive treatment as usual or treatment as usual plus up to four sessions of BCBT during their inpatient stay. They will complete monthly follow-up assessments for six months after leaving the hospital.

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy

Trial Details

FieldValue
Enrollment Target 213 participants
Start Date 2020-01-20
Est. Completion 2023-08-15
Phase NA

Sponsor

Hartford Hospital

75 total trials

What the Registry Record Tells You About NCT04168645

The ClinicalTrials.gov registry entry for NCT04168645 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 213 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hartford Hospital, which has 75 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cognitive Behavioral Therapy is the first listed.

NCT04168645 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04168645 about?

NCT04168645 is a clinical study titled "Inpatient Cognitive-Behavioral Therapy to Reduce Suicide Risk Post-Discharge". The goal of this randomized-controlled trial is to determine whether adding brief cognitive-behavioral therapy for suicide prevention (BCBT) to inpatient treatment improves suicide-related outcomes after the person leaves the hospital. The study will also determine whether being diagnosed with a sub...

What is the current status of trial NCT04168645?

This trial is currently completed. It is a NA study. The enrollment target is 213 participants. The study started on 2020-01-20. Estimated completion is 2023-08-15.

What interventions are being tested in trial NCT04168645?

The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT04168645?

This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.